| | | 00612 | | 18.08.1999 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | | 08.08. | | | | 08.08. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Tetravac | suspension injectable | ( 20 UI, 40 UI) | J07CA02 | | | 02 | Tetravac | | ( 40 U, 8 U, 32 U, 20 UI, 40 UI, 25 mcg) | Codice | | | 03 | Tetravac | | ( 20 UI, 40 UI, 25 mcg, 62 U) | | |
|
|
